Omburtamab I-131

DB17124InvestigationalSmall molecule

Omburtamab I-131: Overview.

Mechanism: Pharmacologically active on CD276 antigen
Curator reviewed
Also known as: 131 I-omburtamab · 131-I-8H9 monoclonal antibody · 131I-burtomab · 131I-omburtamab · Burtomab I-131

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 24, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 16 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Omburtamab I-131, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.